14 September 2023
Cancers | Highly Cited Papers and Hot Topic Special Issues on Hepatocellular Carcinoma Research


We are delighted to share some highly cited papers on hepatocellular carcinoma research that were published in the journal Cancers (ISSN: 2072-6694) in 2021 and 2022. In addition, some Special Issues on this topic are open for submission. The following is a list of articles and Special Issues which we believe will be of interest to you.

“MAPK/ERK Signaling Pathway in Hepatocellular Carcinoma”
by Hyuk Moon and Simon Weonsang Ro
Cancers 2021, 13(12), 3026; https://doi.org/10.3390/cancers13123026
Available online: https://www.mdpi.com/2072-6694/13/12/3026

“Emerging Therapies for Hepatocellular Carcinoma (HCC)”
by Eesha Chakraborty and Devanand Sarkar
Cancers 2022, 14(11), 2798; https://doi.org/10.3390/cancers14112798
Available online: https://www.mdpi.com/2072-6694/14/11/2798

“Tumor-Associated Macrophages in Hepatocellular Carcinoma Pathogenesis, Prognosis and Therapy”
by Konstantinos Arvanitakis, Triantafyllia Koletsa, Ioannis Mitroulis and Georgios Germanidis
Cancers 2022, 14(1), 226; https://doi.org/10.3390/cancers14010226
Available online: https://www.mdpi.com/2072-6694/14/1/226

“The Systemic Inflammatory Response Identifies Patients with Adverse Clinical Outcome from Immunotherapy in Hepatocellular Carcinoma”
by Ambreen Muhammed, Claudia Angela Maria Fulgenzi, Sirish Dharmapuri, Matthias Pinter, Lorenz Balcar, Bernhard Scheiner, Thomas U. Marron, Tomi Jun, Anwaar Saeed, Hannah Hildebrand et al.
Cancers 2022, 14(1), 186; https://doi.org/10.3390/cancers14010186
Available online: https://www.mdpi.com/2072-6694/14/1/186

“Transarterial Chemoembolization (TACE) Plus Sorafenib Compared to TACE Alone in Transplant Recipients with Hepatocellular Carcinoma: An Institution Experience”
by Maen Abdelrahim, David Victor, Abdullah Esmail, Sudha Kodali, Edward A. Graviss, Duc T. Nguyen, Linda W. Moore, Ashish Saharia, Robert McMillan, Joy N. Fong et al.
Cancers 2022, 14(3), 650; https://doi.org/10.3390/cancers14030650
Available online: https://www.mdpi.com/2072-6694/14/3/650

“Hepatocellular Carcinoma: Molecular Pathogenesis and Therapeutic Advances”
by Blanca Cucarull, Anna Tutusaus, Patricia Rider, Tania Hernáez-Alsina, Carlos Cuño, Pablo García de Frutos, Anna Colell, Montserrat Marí and Albert Morales
Cancers 2022, 14(3), 621; https://doi.org/10.3390/cancers14030621
Available online: https://www.mdpi.com/2072-6694/14/3/621

Recent Advances in Hepatobiliary Cancers: From Diagnosis to Treatment

Edited by: Dr. Ilyas Sahin
Submission deadline: 30 November 2023

Efficacy and Complications of Liver Resection for Liver Cancer

Edited by: Prof. Dr. Massimo Rossi, Prof. Dr. Quirino Lai and Prof. Dr. Silvia Quaresima
Submission deadline: 20 December 2023

 

An Update on Surgical Treatment for Hepato-Pancreato-Biliary Cancers

Edited by: Dr. Nikolaos Machairas, Dr. Stylianos Kykalos and  Dr. Dimitrios Schizas
Submission deadline: 31 December 2023

Radiology for Diagnosis and Treatment of Liver Cancer

Edited by: Prof. Dr. Takahito Nakajima and Dr. Wenchao Gu
Submission deadline: 20 July 2024

We hope this announcement will provide useful information for this field.

Back to TopTop